Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meriofert vs Fostipur in PCOS Patients Undergoing IVF/ICSI
NCT02785822Phase 4Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Feb 2017
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of human menopausal gonadotrophin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Quantity of mature oocytes respect to the total oocytes at 30 days. Started Feb 2017; status: terminated.
02
Drugs
human menopausal gonadotrophin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02785822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785822.